Correlation between the induction of Th1 cytokines by an attenuated equine infectious anemia virus vaccine and protection against disease progression

Journal of General Virology

Volumn 88, Issue 3, 2007, Pages 998-1004

  Zhang, Xiaoyan ^a   Wang, Ying ^b,c   Liang, Hua ^a   Wei, Li ^b   Xiang, Wenhua ^b   Shen, Rongxian ^b   Shao, Yiming ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b Harbin Institute   (China)

^c SHANGHAI MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EQUINE INFECTIOUS ANEMIA VIRUS VACCINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; LIVE VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; EQUINE INFECTIOUS ANEMIA VIRUS; FEVER; HORSE; HORSE DISEASE; IMMUNE RESPONSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL; VIRULENCE; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN; WILD TYPE;

ANIMALS; CYTOKINES; DISEASE PROGRESSION; EQUINE INFECTIOUS ANEMIA; GENE EXPRESSION; HORSES; INFECTIOUS ANEMIA VIRUS, EQUINE; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, VIRAL; TH1 CELLS; VACCINES, ATTENUATED; VIRAL LOAD; VIRAL VACCINES;

ANIMALIA; EQUIDAE; EQUINE INFECTIOUS ANEMIA VIRUS; EQUUS ASINUS;

EID: 33847688579     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.82416-0     Document Type: Article

References (16)

1. Connolly, N. C., Riddler, S. A. & Rinaldo, C. R. (2005). Proinflammatory cytokines in HIV disease-a review and rationale for new therapeutic approaches. AIDS Rev 7, 168-180.
2. Curran, J. A., Argyle, D. J., Cox, P., Onions, D. E. & Nicolson, L. (1994). Nucleotide sequence of the equine interferon gamma cDNA. DNA Seq 4, 405-407.
3. Goulder, P. J. & Watkins, D. I. (2004). HIV and SIV CTL escape: implications for vaccine design. Nat Rev Immunol 4, 630-640.
4. Hammond, S. A, Cook S. J., Lichtenstein, D. L., Issel, C. J. & Montelaro, R. C. (1997). Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process. J Virol 71, 3840-3852.
5. Jin, X, Bauer, D. E, Tuttleton, S. E., Lewin, S., Gettie, A, Blanchard, J., Irwin, C. E., Safrit, J. T., Mittler, J. & other authors (1999). Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 189, 991-998.
6. Kono, Y., Kobayashi, K. & Fukunaga, Y. (1973). Antigenic drift of equine infectious anemia virus in chronically infected horses. Arch Gesamte Virusforsch 41, 1-10.
7. Li, F, Craigo, J. K., Howe, L., Steckbeck J. D., Cook S, Issel, C. & Montelaro, R. C. (2003). A live attenuated equine infectious anemia virus proviral vaccine with a modified S2 gene provides protection from detectable infection by intravenous virulent virus challenge of experimentally inoculated horses. J Virol 77, 7244-7253.
8. Liang, H., He, X, Shen, R. X., Shen, T., Tong, X., Ma, Y., Xiang, W. H., Zhang, X. Y. & Shao, Y. M. (2006). Combined amino acid mutations occurring in the envelope closely correlate with pathogenicity of EIAV. Arch Virol 151, 1387-1403.
9. McGuire, T. C., Fraser, D. G. & Mealey, R. H. (2004). Cytotoxic T lymphocytes in protection against equine infectious anemia virus. Anim Health Res Rev 5, 271-276.
10. Ogg, G. S., An, X., Bonhoeffer, S, Dunbar, P. R., Nowak M. A., Monard, S., Segal, J. P., Cao, Y., Rowland-Jones, S. L. & other authors (1998). Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279, 2103-2106.
11. Pare, J. & Simard, C. (2004). Comparison of commercial enzyme-linked immunosorbent assays and agar gel immunodiffusion tests for the serodiagnosis of equine infectious anemia. Can J Vet Res 68, 254-258.
12. Rwambo, P. M., Issel, C. J., Adams, W. V., Jr, Hussain, K. A., Miller, M. & Montelaro, R. C. (1990). Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection. Arch Virol 111, 199-212.
13. Schmitz, J. E., Kuroda, M. J., Santra, S., Sasseville, V. G. Simon, M. A., Lifton, M. A., Recz, P., Tenner-Racz, K., Dalesandro, M. & other authors (1999). Control of viremia in simian immunodeficiency virus infection by CD8 + lymphocytes. Science 283, 857-860.
14. Shen, R. X., Xu, Z. D., He, X. S. & Zhang, S. X. (1979). Study on immunological methods of equine infectious anemia. China Agric Sci 4, 1-15 (in Chinese).
15. Shen, T., Liang, H., Tong, X., Fan, X., He, X., Me, Y., Xiang, W, Shen, R., Zhang, X. & Shao, Y. (2006). Amino acid mutations of the infectious clone from Chinese EIAV attenuated vaccine resulted in reversion of virulence. Vaccine 24, 738-749.
16. Wang, Y., Wei, L. L., Zhang, X. Y., Wu, D. L., Xiang, W. H., Wang, X. J., Lv, X. L., Shen, R. X. & Shao, Y. M. (2005). Evaluation of IL-2 expressing level in PBMC of EIAV vaccinated horses. China Biotechnology 25, 55-59 (in Chinese).